February 21, 2025

FDA Approves First Cerebrotendinous Xanthomatosis Treatment

The FDA has approved Ctexli (chenodiol) as the first treatment for cerebrotendinous xanthomatosis, a rare lipid storage disorder.

Conexiant

February 20, 2025

Medical Oddities: Sugar Sensors in the Heart?

Sugar sensors are found in the heart. Tea ingredient turned into hydrogel. Mind-reading is getting closer. And more.

Conexiant

February 19, 2025

CRISPR Successfully Removes Extra Chromosome 21

Researchers demonstrate first successful targeted removal of extra chromosome 21 in Down syndrome cells using CRISPR-Cas9, achieving up to 30.6% effectiveness in laboratory studies.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 12, 2025

FDA Approves Mirdametinib for NF1-Associated Plexiform Neurofibromas

Data from the phase III ReNeu trial showed the kinase inhibitor led to an overall response rate of 41% in adult patients and 52% in pediatric patients.

Conexiant

February 03, 2025

IED Shows High Psychiatric, Medical Comorbidity

95.7% of individuals with IED had at least one psychiatric diagnosis, with strong links to neurological and somatic conditions, study shows.

Conexiant

January 31, 2025

Higher Antipsychotic Doses Linked to TD Risk

Doses greater than 75 mg/d of antipsychotics significantly increased the risk of tardive dyskinesia, with odds ratios up to 3.5, according to a claims database study of corporate healthcare beneficiaries.

Conexiant

January 30, 2025

RFK Jr.’s Vocal Cord Surgery Unapproved in U.S.

“My voice doesn’t really get tired. It just sounds terrible." — Robert F. Kennedy Jr.

Conexiant

January 28, 2025

Heavy Cannabis Use Linked to Altered Memory Processing

New research examining 1003 young adults shows persistent reductions in working memory-related brain activation among heavy cannabis users, independent of recent use or substance dependence diagnosis.

Conexiant